GLP-1s may not shrink muscles as much as we thought, study suggests
The Washington Post • • general
Key Points:
- New research addresses concerns about the impact of GLP-1 weight-loss drugs like Ozempic on muscle mass, which has been a topic of controversy among scientists, doctors, and the public.
- Previous large studies indicated that users of GLP-1 drugs such as Zepbound and Wegovy might experience disproportionate muscle loss alongside fat loss.
- The latest findings suggest that while muscle loss is a concern, incorporating exercise is crucial for individuals taking these medications to help preserve muscle mass.
- This research provides a more nuanced understanding of the effects of GLP-1 drugs, emphasizing the role of physical activity in mitigating potential muscle-related side effects.
